STATE OF THE ART BP ASSESSMENT
|
|
- Damon Norman
- 5 years ago
- Views:
Transcription
1
2 STATE OF THE ART BP ASSESSMENT PROFESSOR MOLECULAR PHARMACOLOGY CONWAY INSTITUE UNIVERSITY COLLEGE DUBLIN CO-CHAIRMAN BLOOD PRESCSURE MANAGEMENT IN LOW RESOURCE SETTINGS CENTRE FOR INTERNATIONAL HUMANITARIAN COOPERATION FORDHAM UNIVERSITY NEW YORK MEDICAL DIRECTOR dabl LIMITED DUBLIN IRELAND
3 LESSONS FROM CLINICAL PRACTICE
4 SCIPIONE RIVA-ROCCI NICOLAI SERGEIVICH KOROTKOV 1910
5 CONVENTIONAL BP MEASUREMENT CLINIC SPHYGMO TEMPERATURE HEIGHT HUMIDITY POSITION & TILT NOISE LEVEL OF HG OBSERVER CLOGGED VENT TRAINING MAINTENANCE BIAS STETHOSCOPE DIGIT PREFERENCE SUBJECT INATTENTION ANXIETY RAPPORT RECENT EXERCISE HEARING & VISION MEAL OR TOBACCO DISTANCE OBESITY ELDERLY CUFF/BLADDER ARRHYTHMIA CUFF CONDITION POSTURE APPLICATION ARM LEVEL BLADDER SIZE ARM SUPPORT BLADDER POSITION RIGHT OR LEFT?
6 WHITE COAT HYPERTENSION 20 25% MASKED HYPERTENSION 10 15% CBPM ~ INCORRECT DIAGNOSIS 30 40%
7 The Charitable Infirmary at Jervis Street Blood Pressure Unit founded 1979
8
9 Faced with a patient with borderline hypertension, the doctor should be slow to diagnose hypertension until some attempt has been made to categorise the behaviour of blood pressure over time: ambulatory blood pressure measurement is the best way to do this. O Brien E. BMJ 1988:297;
10 MEASUREMENT ACCURACY
11 SERIES OF VALIDATION PROTOCOLS Stergiou G et al. BP Monit 2010;15:39 48.
12
13 USER-FRIENDLY SOFTWARE
14 LEVELS OF NORMALITY WINDOWS OF 24-H PROFILE dabl Ireland Owens P, Atkins N, O Brien E. Diagnosis of White Coat Hypertension by Ambulatory Blood Pressure Monitoring. Hypertension 1999;34:
15 NORMAL 24-HOUR PATTERN dabl Ireland
16 COMPUTER-GENERATED REPORTS dabl Ireland The ABPM indicates normal 24-hour systolic & diastolic blood pressure (128 / 78 mmhg daytime, 110 / 62 mmhg night-time).
17 CONCISE REPORT
18
19 Hypertension published online Jan 26 th 2009 ABPM TREND REPORT
20 CLINICAL USE n Mean White-Coat Window SBP DBP HR Daytime SBP DBP HR Night-time SBP DBP HR hour SBP DBP HR RESEARCH
21
22 WHITE COAT HYPERTENSION 20-25% hypertensive population 2011 dabl Limited The ABPM shows marked white-coat hypertension (205/100 mmhg) with otherwise normal 24-hour systolic & diastolic blood pressure (128/68 mmhg daytime and 112/54 mmhg night-time). OFFICE HYPERTENSION AMBULATORY NORMOTENSION 156/88 mmhg 128/68 mmhg
23 MASKED HYPERTENSION 10-15% of general population 2011 dabl Limited The ABPM shows mild daytime systolic & diastolic hypertension (147 / 93 mmhg) and normal nighttime systolic & diastolic blood pressure (111 / 66 mmhg). OFFICE NORMOTENSION AMBULATORY HYPERTENSION 124/62 mmhg 147/93 mmhg
24 DIPPERS AND NON-DIPPERS DIPPERS Day/Night > 10/5 mmhg NON-DIPPERS Day/Night < 10/5 mmhg DIPPERS Stroke 3 % NON-DIPPERS Stroke 23 % O Brien et al. Lancet 1988
25 ADJUSTED 5-YEAR RISK OF CARDIOVASCULAR DEATH ACCORDING TO CBPM & ABPM Nighttime 24-hour Daytime Clinic Nighttime 24-hour Daytime Clinic Adjusted for other covariates Dolan et al. Hypertension 2005;46:1-6
26 DIPPING PATTERN 2011 dabl Limited The ABPM shows severe daytime systolic hypertension (181 mmhg), moderate daytime diastolic hypertension (117 mmhg) and normal night-time systolic & diastolic blood pressure (111/68 mmhg).
27 NON-DIPPING PATTERN 2011 dabl Limited The ABPM shows severe 24-hour systolic & diastolic hypertension (210/134 mmhg daytime and 205/130 mmhg night-time).
28 MORNING SURGE 2011 dabl Limited
29 ISOLATED SYSTOLIC HYPERTENSION 2011 dabl Limited The ABPM indicates severe 24-hour isolated systolic hypertension (176/68 mmhg daytime and 169/70 mmhg night-time).
30 AUTONOMIC FAILURE 2011 dabl Limited
31 HYPERTENSIVE - NON DIPPER Shortoprilol 50 mg mane
32 HYPERTENSIVE - NON DIPPER 2011 dabl Limited Longoprolol 20 mg mane
33 WHAT DO THE INTERNATIONAL GUIDELINES SAY?
34 ABPM GUIDELINES INDICATION BHS 2000 ESH 2003 BRAZIL 2005 AHA 2005 JAPAN 2012 AUST 2012 SUSPECTED WCH Yes Yes Yes Yes Yes Yes WC EFFECT Yes Yes - - Yes Yes SUSPECTED MH Yes Yes Yes Yes Yes Yes DIPPING STATUS Yes Yes - Yes Yes Yes RESISTANT HT Yes Yes - Yes Yes Yes DRUG EFFICACY Yes Yes Yes Yes Yes Yes HYPOTENSION Yes Yes Yes Yes Yes Yes BP VARIABILITY Yes - SECONDARY HT Yes - SLEEP APNOEA Yes
35 NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE (NICE) GUIDELINE 2011
36 IF THE CLINIC BLOOD PRESSURE IS 140/90 MMHG OR HIGHER, OFFER AMBULATORY BLOOD PRESSURE MONITORING (ABPM) TO CONFIRM THE DIAGNOSIS OF HYPERTENSION. NICE Final Recommendation 2011
37 GENERAL HYPERTENSION GUIDELINES INDICATION JNC VII 2003 BHS IV 2004 ESC ESH 2007 LATIN AMER 2009 ITALY 2008 CHEP 2011 SA 2012 TAI- WAN 2012 SUSPECTED HT YES NICE 2011 SUSPECTED WCH Yes Yes Yes Yes Yes Yes Yes Yes Yes WC EFFECT Yes Yes SUSPECTED MH Yes Yes - Yes - No DIPPING STATUS - Yes Yes Yes Yes Yes Yes - No RESISTANT HT Yes Yes Yes Yes Yes Yes Yes Yes - DRUG EFFICACY - Yes Yes Yes Yes Yes Yes - No HYPOTENSION Yes Yes Yes Yes Yes Yes - Yes No BP VARIABILITY - Yes Yes Yes Yes Yes Yes Yes -
38 NICE OBJECTIVE SAVE MONEY FOR THE NHS Lancet 2011;736:1184-7
39 PHARMACOLOGICAL TRIALS OF CV DRUGS
40 THE TIME HAS SURELY COME WHERE STUDIES OF ANTIHYPERTENSIVE DRUG EFFICACY WHICH DO NOT ASSESS BLOOD PRESSURE OVER 24 HOURS SHOULD NO LONGER BE ACCEPTABLE. O Brien E. J Hypertens 1989:7;
41 Millar Craig et al. BMJ 1979;i:
42 Millar Craig et al. BMJ 1979;i:
43 The circadian rhythm of blood pressure raises many questions about the timing of antihypertensive drug dosage and the effects of traditional regimens. Single measurements in outpatient clinics are unlikely to yield useful information on the effects of drugs on this basic cycle. If treatment aims at lowering blood pressure to a "normal level (140/90 mm Hg) clearly it is desirable to lower it to that level throughout the 24-hour cycle. Millar Craig et al. BMJ 1979;i:
44
45
46 Hypertension published online Jan 26 th 2009
47 VISIT-TO-VISIT BPV IN ASCOT-BPLA 4.5 Hypertension published online Jan 26 th 2009 Average within-visit CV SBP Atenolol Amlodipine Baseline 3 months 1 year 2 year 3 year 4 year 5 year Follow-up
48 BLOOD PRESSURE VARIABILITY Marked BPV Less BPV
49 HOPE STUDY New Eng J Med 2002 RAMIPRIL ~ REDUCTION IN CV MORTALITY REDUCTION IN BP ~ 3/2 mmhg ACE INHIBITORS ~ HIGH-RISK PATIENTS ABPM SUB-STUDY ~ 1 YEAR LATER WHOPPING 17/8 mmhg NOCTURNAL FALL 10/4 mmhg REDUCTION IN 24-H ABPM
50 REAL-TIME ANALYSIS OF ABPM IS ESSENTIAL
51 ABPM Page (Rejected ABPM)
52 ABPM Page (Accepted ABPM)
53 PHARMACOLOGICAL TRIALS OF NON-CV DRUGS
54 Various Technologies and Means to Measure Blood Pressure in Clinical Trials
55 SELF-MEASUREMENT OF BLOOD PRESSURE (SBPM)
56 ESH RECOMMENDATIONS FOR SBPM Parati G,Stergiou GS, O Brien E, et al on behalf of the ESH Working Group on Blood Pressure Monitoring. European Society of Hypertension guidelines for blood pressure monitoring at home: J Hypertens 2008, 26: m REST, 30 m NO SMOKING or CAFFEINE, RELAXED SEATED, BACK SUPPORT, ARM ON TABLE, LEGS UNCROSSED 7 DAYS OF MEASUREMENTS 2 MEASUREMENTS, 1-2 MIN INTERVALS, AM & PM DISCARD FIRST DAY MEASUREMENTS AVERAGE 6 DAYS MEASUREMENT APPROXIIMATE EQUIVALENT TO DAYTIME ABPM NO NOCTURNAL DATA, NO PATTERNS ABPM and SBPM ~ DIFFERENT DATA ~ COMPLIMENTARY TECHNIQUES
57 Drug Information Journal, 2011; 45: In my view, a better question regarding ABPM is whether all systemically available drugs intended for chronic use merit a careful assessment of their effects on vital signs by ABPM. Norman Stockbridge. Drug Information Journal, 2011; 45:
58 SINCE CBPM IN 1896 SUPERLATIVE TECHNOLOGY
59 Hypertension published online Jan 26 th 2009 CARD(X)PLORE DEVICE
60 ABPM Variability
61 Hypertension published online Jan 26 th 2009
62 From the scientific viewpoint, we believe that it is now time to utilize the technique of ABPM to obtain a fuller understanding of the patterns of noncardiovascular drug-induced BP responses than was ever possible with CBPM. J Clin Hypertens 2012
63 CONCLUSION ~ PLEA PHARMACOLOGICL TRIALS ~ ABPM SCIENCE MUST DIRECT INDUSTRY ACCURATE & EFFICIENT ABPM HARDWARE DUAL OR TREBLE PURPOSE DEVICES STANDARDISED ANALYTICAL SOFTWARE CENTRAL HOSTING & FEED-BACK REAL-TIME MONITORING & ANALYSIS SCIENTIFIC REALITY ~ PROCEDURAL APATHY
64
BLOOD PRESSURE MEASUREMENT HOME BASED OR OFFICE BP MONITORING WHICH, HOW AND WHEN?
BLOOD PRESSURE MEASUREMENT HOME BASED OR OFFICE BP MONITORING WHICH, HOW AND WHEN? DECLARATION OF INTEREST Medical Director and Chairman, Advisory Board dabl Ltd., Dublin, Ireland. BLOOD PRESSURE MEASUREMENT
More informationAmbulatory Blood Pressure Monitoring Clinical Practice Recommendations
Acta Medica Marisiensis 2016;62(3):350-355 DOI: 10.1515/amma-2016-0038 UPDATE Ambulatory Blood Pressure Monitoring Clinical Practice Recommendations Mako Katalin *, Ureche Corina, Jeremias Zsuzsanna University
More informationUse and Interpretation of Home Blood Pressure Monitoring
Use and Interpretation of Home Blood Pressure Monitoring BLOOD PRESSURE in year 2015 PARAMETERS TODAY Gianfranco Parati University of Milano-Bicocca & Ospedale S.Luca, IRCCS, Istituto Auxologico Italiano
More informationIs Traditional Clinic Blood Pressure Dead?
Royal College of Physicans May 16 th 2017 Is Traditional Clinic Blood Pressure Dead? Professor Bryan Williams MD FRCP FAHA FESC Chair of Medicine UCL Director National Institute for Health Research Biomedical
More informationSlide notes: References:
1 2 3 Cut-off values for the definition of hypertension are systolic blood pressure (SBP) 135 and/or diastolic blood pressure (DBP) 85 mmhg for home blood pressure monitoring (HBPM) and daytime ambulatory
More informationAmbulatory BP Monitoring: Getting the Diagnosis of Hypertension Right. Anthony J. Viera, MD, MPH, FAHA Professor and Chair
Ambulatory BP Monitoring: Getting the Diagnosis of Hypertension Right Anthony J. Viera, MD, MPH, FAHA Professor and Chair Objectives Review limitations of office BP in making a correct diagnosis of hypertension
More informationCopyright Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
Devices and technology 261 Validation of the ROSSMAX blood pressure measuring monitor according to the European Society of Hypertension International Protocol for Validation of Blood Pressure Measuring
More informationANTIHYPERTENSIVE DRUG THERAPY IN CONSIDERATION OF CIRCADIAN BLOOD PRESSURE VARIATION*
Progress in Clinical Medicine 1 ANTIHYPERTENSIVE DRUG THERAPY IN CONSIDERATION OF CIRCADIAN BLOOD PRESSURE VARIATION* Keishi ABE** Asian Med. J. 44(2): 83 90, 2001 Abstract: J-MUBA was a large-scale clinical
More informationMaking ambulatory blood pressure monitoring accessible in pharmacies Kirstyn James a, Eamon Dolan a and Eoin O Brien b
134 Clinical methods and pathophysiology Making ambulatory blood pressure monitoring accessible in pharmacies Kirstyn James a, Eamon Dolan a and Eoin O Brien b Objectives Ambulatory blood pressure measurement
More informationAssessing Blood Pressure for Clinical Research: Pearls & Pitfalls
Assessing Blood Pressure for Clinical Research: Pearls & Pitfalls Anthony J. Viera, MD, MPH, FAHA Department of Family Medicine Hypertension Research Program UNC School of Medicine Objectives Review limitations
More informationAFFORDABLE TECHNOLOGY
World Health Organization AFFORDABLE TECHNOLOGY BLOOD PRESSURE MEASURING DEVICES FOR LOW RESOURCE SETTINGS CARDIOVASCULAR DISEASES Blood Pressure Measurement in Low Resource Settings Annex 1: Blood Pressure
More informationDR JIRAR TOPOUCHIAN PROF PAROUNAK ZELVEIAN PROF ROLAND ASMAR. September 8 th, Principal Investigator and Study Chair:
Page 1 of 10 Validation of the automatic blood pressure measurements device, the OMRON EVOLV (HEM- 7600 T-E) in Pregnancy according to the Modified European Society of Hypertension International Protocol
More informationAmbulatory Blood Pressure Monitoring for the Effective Management of Antihypertensive Drug Treatment
Clinical Therapeutics/Volume 38, Number 1, 216 Review Article Ambulatory Blood Pressure Monitoring for the Effective Management of Antihypertensive Drug Treatment Eoin O Brien, DSc, MD 1 ; and Eamon Dolan,
More informationAmbulatory blood pressure measurement (ABPM) is being used increasingly in clinical practice.
Hypertension AMBULATORY BLOOD PRESSURE MONITORING IN THE MANAGEMENT OF HYPERTENSION c WHY Correspondence to: Professor Eoin O Brien, Blood Pressure Unit and ADAPT Centre, Beaumont Hospital, Dublin 9, Ireland;
More informationAGING, BLOOD PRESSURE & CARDIOVASCULAR DISEASE EVENT RISK. Michael Smolensky, Ph.D. The University of Texas Austin & Houston
AGING, BLOOD PRESSURE & CARDIOVASCULAR DISEASE EVENT RISK Michael Smolensky, Ph.D. The University of Texas Austin & Houston Disclosures Partner: Circadian Ambulatory Diagnostics Consultant: Spot On Sciences
More informationTodd S. Perlstein, MD FIFTH ANNUAL SYMPOSIUM
Todd S. Perlstein, MD FIFTH ANNUAL SYMPOSIUM Faculty Disclosure I have no financial interest to disclose No off-label use of medications will be discussed FIFTH ANNUAL SYMPOSIUM Recognize changes between
More informationImportance of Ambulatory Blood Pressure Monitoring in Adolescents
Importance of Ambulatory Blood Pressure Monitoring in Adolescents Josep Redon, MD, PhD, FAHA Internal Medicine Hospital Clinico Universitario de Valencia University of Valencia CIBERObn Instituto de Salud
More informationChapter-V. Summary, Conclusions and Recommendations
Summary, Conclusions and Recommendations INTRODUCTION The work included in this thesis entitled, Circadian heart rate and blood pressure variability in apparently healthy subjects using ABPM has been divided
More informationWhite coat and masked hypertension
White coat and masked hypertension Conflict of interest Support from Spacelabs, Microlife. Honoraria from Novartis, Elpen, Boeringer-Ingelheim, CANA, Lilly, MSD, Sanofi, Menarini, Ciezi, Astra-Zeneca.
More informationHipertensión enmascarada. Alejandro de la Sierra Hospital Mútua Terrassa Universitat de Barcelona
Hipertensión enmascarada Alejandro de la Sierra Hospital Mútua Terrassa Universitat de Barcelona HTA enmascarada Definición Prevalencia Características clínicas Riesgo derivado Asociación con LOD Progresión
More informationCurrent strategies for managing hypertension
Eπίκαιρο Άρθρο Ambulatory blood pressure monitoring: the gold standard for the diagnosis and management of hypertension in general practice Eoin O Brien ABSTRACT Although ambulatory blood pressure measurement
More informationTalking about blood pressure
Talking about blood pressure Mrs Khan 56 BP 158/99 BMI 32 Total cholesterol 5.4 (HDL 0.8) HbA1c 43 She has been promising to do more exercise and eat more healthily for the last 2 years but her weight
More informationDementia Retinal arteriolar narrowing and HT. What comes first?
Dementia 2016 Retinal arteriolar narrowing and HT What comes first? Jan A. Staessen, MD, PhD University of Leuven / Maastricht University jan.staessen@med.kuleuven.be / ja.staessen@maastrichtuniversity.nl
More informationBlood Pressure Monitoring in Chronic Kidney Disease
Blood Pressure Monitoring in Chronic Kidney Disease Aldo J. Peixoto, MD FASN FASH Associate Professor of Medicine (Nephrology), YSM Associate Chief of Medicine, VACT Director of Hypertension, VACT American
More informationInsulin resistance influences 24h heart rate and blood pressure variabilities and cardiovascular autonomic modulation in normotensive healthy adults
Insulin resistance influences 24h heart rate and blood pressure variabilities and cardiovascular autonomic modulation in normotensive healthy adults Ochoa JE 1, Correa M 2, Valencia AM 2, Gallo J 2, McEwen
More information1. Department of Gynecology and Obstetrics, St. Joseph's Hospital Berlin Tempelhof, Germany
Page 1 of 9 Validation of the TONOPORT VI ambulatory blood pressure monitor, according to the European Society of Hypertension International Protocol revision 2010 Michael Abou-Dakn 1, Cornelius Döhmen
More informationThe accurate measurement of blood pressure
Position Paper ASH Position Paper: Home and Ambulatory Blood Pressure Monitoring When and How to Use Self (Home) and Ambulatory Blood Pressure Monitoring Thomas G. Pickering, MD, D Phil; 1 William B. White,
More informationObjectives. Describe results and implications of recent landmark hypertension trials
Hypertension Update Daniel Schwartz, MD Assistant Professor of Medicine Associate Medical Director of Heart Transplantation Temple University School of Medicine Disclosures I currently have no relationships
More informationNew Hypertension Guideline Recommendations for Adults July 7, :45-9:30am
Advances in Cardiovascular Disease 30 th Annual Convention and Reunion UERM-CMAA, Inc. Annual Convention and Scientific Meeting July 5-8, 2018 New Hypertension Guideline Recommendations for Adults July
More informationPrimary hypertension in adults
Primary hypertension in adults NICE provided the content for this booklet which is independent of any company or product advertised Hypertension Welcome NICE published an updated guideline on the diagnosis
More informationAmbulatory blood pressure monitoring is key to improving hypertension diagnosis
Earn 2 CEU Points online Ambulatory blood pressure monitoring is key to improving hypertension diagnosis Professor Bryan Williams Director of the UCL Biomedical Research Centre University College London
More informationOHTAC Recommendation: Twenty-Four-Hour Ambulatory Blood Pressure Monitoring in Hypertension. Ontario Health Technology Advisory Committee
OHTAC Recommendation: Twenty-Four-Hour Ambulatory Blood Pressure Monitoring in Hypertension Ontario Health Technology Advisory Committee May 2012 Background Hypertension in Canada Hypertension occurs when
More informationClinical Medical Policy Department Clinical Affairs Division DESCRIPTION
Ambulatory Blood Pressure Monitoring (ABPM) [For the list of services and procedures that need preauthorization, please refer to www.mcs.com.pr. go to Comunicados a Proveedores, and click Cartas Circulares.]
More informationPatrick Kay, General and Interventional Cardiologist Auckland or healthpoint.co.nz
Patrick Kay, General and Interventional Cardiologist Auckland ipatkay@hotmail.com or healthpoint.co.nz Rotorua 2015 Rotorua 2015 Graphical example of true mean and variation, and of regression to the
More informationValidation of the SEJOY BP-1307 upper arm blood pressure monitor for home. blood pressure monitoring according to the European Society of Hypertension
Validation of the SEJOY BP-1307 upper arm blood pressure monitor for home blood pressure monitoring according to the European Society of Hypertension International Protocol revision 2010 Short title: Validation
More informationCombination Therapy for Hypertension
Combination Therapy for Hypertension Se-Joong Rim, MD Cardiology Division, Yonsei University College of Medicine, Seoul, Korea Goals of Therapy Reduce CVD and renal morbidity and mortality. Treat to BP
More informationGETTING THE NUMBERS RIGHT: ACCURATE MEASUREMENT OF BLOOD PRESSURE
GETTING THE NUMBERS RIGHT: ACCURATE MEASUREMENT OF BLOOD PRESSURE Pamela B. Morris, MD, FACC, FAHA, FASPC, FNLA Professor Medicine and Cardiovascular Diseases Director, Seinsheimer Cardiovascular Health
More informationVital Signs. Vital Signs. Pulse. Temperature. Respiration. Blood Pressure
Vital Signs Jarvis, Chapter 9 Vital Signs Classic Vital Signs TPR/BP Temperature Pulse Respirations Blood Pressure Additional Vital Signs Height Weight BMI (Kg/m2) or (702Xlbs/in2) Supine, orthostatic
More informationDr Diana R Holdright. MD, FRCP, FESC, FACC, MBBS, DA, BSc. Consultant Cardiologist HYPERTENSION.
Dr Diana R Holdright MD, FRCP, FESC, FACC, MBBS, DA, BSc. Consultant Cardiologist HYPERTENSION www.drholdright.co.uk Blood pressure is the pressure exerted on the walls of the arteries when the heart pumps;
More informationDevice Judgement Recommended
dabl Educational Trust Validation Checklist Device Judgement Recommended Manufacturer IEM Device Stabil O Graph Category Upper Arm (Self) Mode Oscillometric Protocol Reference BHS + ESH Westhoff TH, Schmidt
More informationAppendix F: Clinical evidence tables
378 Appendix F: F.1 Blood pressure variability STUDY 1 P. M. Rothwell, S. C. Howard, E. Dolan, E. O'Brien, J. E. Dobson, B. Dahlof, N. R. Poulter, and P. S. Sever. Effects of beta blockers and calciumchannel
More information가정혈압의활용 CARDIOVASCULAR CENTER. Wook Bum Pyun M.D., Ph.D. HOME BLOOD PRESSURE MONITORING. Ewha Womans University, school of Medicine
가정혈압의활용 HOME BLOOD PRESSURE MONITORING CARDIOVASCULAR CENTER Wook Bum Pyun M.D., Ph.D. pwb423@ewha.ac.kr Ewha Womans University, school of Medicine Non-Invasive Blood Pressure Measurement 5-20% Resistant
More informationOutcomes and Perspectives of Single-Pill Combination Therapy for the modern management of hypertension
Outcomes and Perspectives of Single-Pill Combination Therapy for the modern management of hypertension Prof. Massimo Volpe, MD, FAHA, FESC, Chair of Cardiology, Department of Clinical and Molecular Medicine
More information24-uur ambulante bloeddrukmeting versus thuisbloedrukmeting
2017 Dementia 24-uur ambulante bloeddrukmeting versus thuisbloedrukmeting Wat gebruiken in de klinische praktijk? Jan A. Staessen, MD, PhD KU Leuven jan.staessen@kuleuven.be BPM Key messages to be made
More informationMaker Spacelabs Healthcare Manufacturer Spacelabs Healthcare. Brand Spacelabs Model OnTrak
Validation Study Result Form Please complete Section 1 to Section 3 of this form and return it to dabl Educational Trust with copies of the validation plots and a digital photograph of the device used
More informationUniversity of Padova, Padua, Italy, and HARVEST Study Group, Italy
University of Padova, Padua, Italy, and HARVEST Study Group, Italy ISOLATED SYSTOLIC HYPERTENSION IN THE YOUNG DOES NOT IMPLY AN INCREASED RISK OF FUTURE HYPERTENSION NEEDING TREATMENT Mos L, Saladini
More informationTreatment of hypertension to achieve blood pressure control
Treatment of hypertension to achieve blood pressure control Item Type Report Authors Peter Mas-Mollinedo Publisher Irish Heart Foundation (IHF) Download date 01/11/2018 18:07:44 Link to Item http://hdl.handle.net/10147/310910
More informationapneabp card(x)plore ABPM-04 Ambulatory Blood Pressure Monitors & Combinations
apneabp card(x)plore ABPM-04 Ambulatory Blood Pressure Monitors & Combinations Meditech Cardiovascular Monitoring Solutions Meditech is one of the worldwide technology leaders in the area of manufacturing
More informationReceived 24 February 2015 Revised 29 April 2015 Accepted 20 May 2015
Original article 1 Clinical practice of ambulatory versus home blood pressure monitoring in hypertensive patients Jorge A. Paolasso, Florencia Crespo, Viviana Arias, Eduardo A. Moreyra, Ariel Volmaro,
More informationThe Evolution To Treatment Of Hypertension With Advanced Formulation
The Evolution To Treatment Of Hypertension With Advanced Formulation Dr. Donald Ang MBChB (UK) FRCP (Edin) MD (UK) CCST Cardiology (UK) FESC (Europe) Consultant Cardiologist Island Hospital Penang High
More informationValidation Study Result Form
Validation Study Result Form Please complete Section 1 to Section 3 of this form and return it to dabl Educational Trust with copies of the validation plots. The requirements for each of these sections
More informationHypertension Update Warwick Jaffe Interventional Cardiologist Ascot Hospital
Hypertension Update 2008 Warwick Jaffe Interventional Cardiologist Ascot Hospital Definition of Hypertension Continuous variable At some point the risk becomes high enough to justify treatment Treatment
More informationCopyright Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
Devices and technology 57 Comparison of wrist-type and arm-type 24-h blood pressure monitoring devices for ambulatory use Takahiro Komori a, Kazuo Eguchi a, Satoshi Hoshide a, Bryan Williams b and Kazuomi
More information4/4/17 HYPERTENSION TARGETS: WHAT DO WE DO NOW? SET THE STAGE BP IN CLINICAL TRIALS?
HYPERTENSION TARGETS: WHAT DO WE DO NOW? MICHAEL LEFEVRE, MD, MSPH PROFESSOR AND VICE CHAIR DEPARTMENT OF FAMILY AND COMMUNITY MEDICINE UNIVERSITY OF MISSOURI 4/4/17 DISCLOSURE: MEMBER OF THE JNC 8 PANEL
More informationTHE NEW ARMENIAN MEDICAL JOURNAL DISTRIBUTION, AWARENESS, TREATMENT, AND CONTROL OF ARTERIAL HYPERTENSION IN YEREVAN (ARMENIA)
THE NEW ARMENIAN MEDICAL JOURNAL Vol.5 (2011), Nо 2, p.29-34 DISTRIBUTION, AWARENESS, TREATMENT, AND CONTROL OF ARTERIAL HYPERTENSION IN YEREVAN (ARMENIA) Zelveian P.H. 1, 2, Podosyan G.A. 2 1 Institute
More informationValidation of the OMRON 705 IT blood pressure measuring device according to the International Protocol of the European Society of Hypertension
Validation of the OMRON 705 IT blood pressure measuring device according to the International Protocol of the European Society of Hypertension M. EL ASSAAD, J. TOPOUCHIAN, G. LABAKI, R. ASMAR L Institut
More informationORIGINAL ARTICLE AMBULATORY BLOOD PRESSURE IN OBESITY. Introduction. Patients and Methods
Vol. 2, Issue 1, pages 31-36 ORIGINAL ARTICLE AMBULATORY BLOOD PRESSURE IN OBESITY By Alejandro de la Sierra, MD Luis M. Ruilope, MD Hypertension Units, Hospital Clinico, Barcelona & Hospital 12 de Octubre,
More informationSpecial articles from the ESH working group on blood pressure monitoring 23
Special articles from the ESH working group on blood pressure monitoring 23 European Society of Hypertension International Protocol revision 2010 for the validation of blood pressure measuring devices
More informationMedical Policy An Independent Licensee of the Blue Cross and Blue Shield Association
Ambulatory Blood Pressure Monitoring Page 1 of 14 Medical Policy An Independent Licensee of the Blue Cross and Blue Shield Association Title: Ambulatory Blood Pressure Monitoring Professional Institutional
More informationHypertension: What s new since JNC 7. Harold M. Szerlip, MD, FACP, FCCP, FASN, FNKF
Hypertension: What s new since JNC 7 Harold M. Szerlip, MD, FACP, FCCP, FASN, FNKF Disclosures Spectral Diagnostics Site investigator Eli Lilly Site investigator ACP IM ITE writing committee NBME Step
More informationPreventing Cardiovascular Disease Stroke Primary Prevention Guidelines. John Potter Professor Ageing & Stroke Medicine University of East Anglia
Preventing Cardiovascular Disease Stroke Primary Prevention Guidelines John Potter Professor Ageing & Stroke Medicine University of East Anglia Preventing Cardiovascular Disease Stroke Primary Prevention
More informationValidation Study Result Form
Validation Study Result Form Please complete Section 1 to Section 5 of this form and return it to dabl Educational Trust with copies of the validation Study Ref. plots. In Section 3 to Section 5, complete
More informationPrevention of Heart Failure: What s New with Hypertension
Prevention of Heart Failure: What s New with Hypertension Ali AlMasood Prince Sultan Cardiac Center Riyadh 3ed Saudi Heart Failure conference, Jeddah, 13 December 2014 Background 20-30% of Saudi adults
More informationHome Blood Pressure Log
Home Blood Pressure Log 2 You or your health care professional may want to monitor your blood pressure at home twice a day for a week or more before appointments to accurately confirm your average blood
More informationQuality ID #122: Adult Kidney Disease: Blood Pressure Management National Quality Strategy Domain: Effective Clinical Care
Quality ID #122: Adult Kidney Disease: Blood Pressure Management National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE: Intermediate
More informationWhat s In the New Hypertension Guidelines?
American College of Physicians Ohio/Air Force Chapters 2018 Scientific Meeting Columbus, OH October 5, 2018 What s In the New Hypertension Guidelines? Max C. Reif, MD, FACP Objectives: At the end of the
More informationand bias, which are known to be present in self-home and in professional office BP measurements taken using the auscultatory technique [7].
Devices and technology 37 Validation of the A&D UM-11 professional hybrid device for office blood pressure measurement according to the International Protocol George S. Stergiou, Periklis P. Giovas, Charilaos
More informationGenetic factors. A number of genetic factors or interactions between genes play a major role in essential hypertension.
Hypertension Blood pressure is a measurement of the force against the walls of your arteries as your heart pumps blood through your body. Hypertension is another term used to describe high blood pressure.
More informationMEDICAL POLICY SUBJECT: AUTOMATED AMBULATORY BLOOD PRESSURE MONITORING
MEDICAL POLICY SUBJECT: AUTOMATED AMBULATORY 02/19/09 PAGE: 1 OF: 5 If a product excludes coverage for a service, it is not covered, and medical policy criteria do not apply. If a commercial product, including
More informationK/DOQI Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease
K/DOQI Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease GUIDELINE 1: GOALS OF ANTIHYPERTENSIVE THERAPY IN CKD Hypertension is common in CKD, and is a risk
More information& Wilkins. a Division of Cardiology, Schulich Heart Centre, b Institute for Clinical and
Original article 333 Optimum frequency of office blood pressure measurement using an automated sphygmomanometer Martin G. Myers a, Miguel Valdivieso a and Alexander Kiss b,c Objective To determine the
More informationAmbulo Ambulatory Blood Pressure Monitoring Systems. Innovative Diagnostics Better Care
Ambulo 2400 Ambulatory Blood Pressure Monitoring Systems Innovative Diagnostics Better Care About Tiba Medical Private medical device company founded in 2003 and based in Portland, Oregon, USA Focused
More informationΚέντρο Υπέρτασης STRIDE-7 Γ Παθολογική Κλινική Πανεπιστημίου Αθηνών Νοσοκομείο Σωτηρία. Υπέρταση και ΣΑΥ. ΓΣ Στεργίου
Κέντρο Υπέρτασης STRIDE-7 Γ Παθολογική Κλινική Πανεπιστημίου Αθηνών Νοσοκομείο Σωτηρία Υπέρταση και ΣΑΥ ΓΣ Στεργίου Search results Items: 4480 14/04/2016 1990 N=35 2000 N=106 2015 N=338 Pages 130 Ref:
More informationDifficult-to-Control & Resistant Hypertension. Anthony Viera, MD, MPH, FAHA Professor and Chair
Difficult-to-Control & Resistant Hypertension Anthony Viera, MD, MPH, FAHA Professor and Chair Objectives Define resistant hypertension Discuss evaluation strategy for patient with HTN that appears difficult
More informationHypertension Management Controversies in the Elderly Patient
Hypertension Management Controversies in the Elderly Patient Juan Bowen, MD Geriatric Update for the Primary Care Provider November 17, 2016 2016 MFMER slide-1 Disclosure No financial relationships No
More informationDisclosures. Funding: CIHR, HSF, AIHS, UHF. Research: Novo Nordisk, CVRx, Valencia. Consulting: Valeant
Hypertension Update Raj Padwal Associate Professor General Internal Medicine and Clinical Pharmacology Director, Hypertension Clinic University of Alberta Disclosures Funding: CIHR, HSF, AIHS, UHF Research:
More informationDisclosures. Learning Objectives. Hypertension: a sprint to the finish Ontario Pharmacists Association 1
Disclosures I have no current or past relationships with commercial entities I have received a speaker s fee from the Ontario Pharmacists Association for this learning activity Laura Tsang PharmD Sunnybrook
More informationInterested parties (organisations or individuals) that commented on the draft document as released for consultation.
23 June 2016 EMA/CHMP/345847/2015 Committee for Medicinal products for Human Use Overview of comments received on ''Guideline on clinical investigation of medicinal products in the treatment of hypertension'
More informationHYPERTENSION: ARE WE GOING TOO LOW?
HYPERTENSION: ARE WE GOING TOO LOW? George L. Bakris, M.D.,F.A.S.N.,F.A.S.H., F.A.H.A. Professor of Medicine Director, ASH Comprehensive Hypertension Center University of Chicago Medicine Chicago, IL USA
More informationChapter-IV. Blood pressure and heart rate variability as function of ovarian cycle in young women
Blood pressure and heart rate variability as function of ovarian cycle in young women INTRODUCTION In human females, the menstrual cycle begins with the onset of menstrual flow on day 1. The menstrual
More informationTreating Hypertension in 2018: What Makes the Most Sense Today?
Treating Hypertension in 2018: What Makes the Most Sense Today? Daniel Blanchard, MD Professor of Medicine UC San Diego Cardiovascular Center La Jolla, California 1 2 Speaker Disclosures Consultant and/or
More informationThe Working Group on Blood Pressure Monitoring of
Brief Review Ambulatory Blood Pressure Measurement What Is the International Consensus? The Working Group on Blood Pressure Monitoring of the European Society of Hypertension (ESH) published recommendations
More informationAutomated Ambulatory Blood Pressure Monitoring for the Diagnosis of Hypertension in Patients with Elevated Office Blood Pressure
Automated Ambulatory Blood Pressure Monitoring for the Diagnosis of Hypertension in Patients with Elevated Office Blood Pressure Policy Number: 1.01.02 Last Review: 9/2014 Origination: 1/1989 Next Review:
More informationThe magnitude and duration of ambulatory blood pressure reduction following acute exercise
Journal of Human Hypertension (1999) 13, 361 366 1999 Stockton Press. All rights reserved 0950-9240/99 $12.00 http://www.stockton-press.co.uk/jhh ORIGINAL ARTICLE The magnitude and duration of ambulatory
More informationThis article will focus on the role of the following in BP management and their prognostic significance:
CARDIOVASCULAR DISORDERS UNIT NO. 2 HOME BLOOD PRESSURE MONITORING, BLOOD PRESSURE VARIABILITY AND MORNING BLOOD PRESSURE SURGE Dr Rohit Khurana, Dr Lucy Priestner ABSTRACT Hypertension is a common chronic
More informationDoes masked hypertension exist in healthy volunteers and apparently well-controlled hypertensive patients?
O R I G I N A L A R T I C L E Does masked hypertension exist in healthy volunteers and apparently well-controlled hypertensive patients? I. Aksoy, J. Deinum, J.W.M. Lenders, Th. Thien *# Department of
More informationThis clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data.
abcd Clinical Study Synopsis for Public Disclosure This clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data. The synopsis
More informationUpdate on HTN and ABPM. Raj Padwal Division of General Internal Medicine University of Alberta
Update on HTN and ABPM Raj Padwal Division of General Internal Medicine University of Alberta Disclosures Funding: CIHR, AIHS, HSF, UHF Research Collaboration: Novo Nordisk, CVRx Consulting: Vivus, Medtronic
More informationDevice Equivalence Evaluation Form
Comparison of the HARTMANN Veroval BPU22 with the AViTA BPM63S Devices Item 9 HARTMANN Veroval BPU22 AViTA BPM63S Pictures Display Image Validation Equivalence ESH 2010 ESH 2002 BHS AAMI Category Arm Type
More informationProtocol. Automated Ambulatory Blood Pressure Monitoring for the Diagnosis of Hypertension in Patients with Elevated Office Blood Pressure
Automated Ambulatory Blood Monitoring for the Diagnosis of Hypertension in Patients with Elevated Office Blood (10102) Medical Benefit Effective Date: 07/01/14 Next Review Date: 03/15 Preauthorization
More informationManaging Hypertension in 2018
MANAGING HYPERTENSION IN 2018 How Do We Work With Conflicting Data and Conflicting Guidelines? Disclosure No relevant financial relationships Robert B. Baron, MD MS Professor and Associate Dean UCSF School
More informationComparison of arbitrary definitions of circadian time periods with those determined by wrist actigraphy in analysis of ABPM data
Journal of Human Hypertension (1999) 13, 449 453 1999 Stockton Press. All rights reserved 0950-9240/99 $12.00 http://www.stockton-press.co.uk/jhh ORIGINAL ARTICLE Comparison of arbitrary definitions of
More information5.2 Key priorities for implementation
5.2 Key priorities for implementation From the full set of recommendations, the GDG selected ten key priorities for implementation. The criteria used for selecting these recommendations are listed in detail
More informationBRIEF COMMUNICATIONS. KEY WORDS: Ambulatory blood pressure monitoring, placebo effect, antihypertensive drug trials.
AJH 1995; 8:311-315 BRIEF COMMUNICATIONS Lack of Placebo Effect on Ambulatory Blood Pressure Giuseppe Mancia, Stefano Omboni, Gianfranco Parati, Antonella Ravogli, Alessandra Villani, and Alberto Zanchetti
More informationHypertension and the SPRINT Trial: Is Lower Better
Hypertension and the SPRINT Trial: Is Lower Better 8th Annual Orange County Symposium on Cardiovascular Disease Prevention Saturday, October 8, 2016 Keith C. Norris, MD, PhD, FASN Professor of Medicine,
More informationRISE, FALL AND RESURRECTION OF RENAL DENERVATION. Michael A. Weber, MD State University of New York Downstate College of Medicine
RISE, FALL AND RESURRECTION OF RENAL DENERVATION Michael A. Weber, MD State University of New York Downstate College of Medicine Michael Weber, Disclosures Research/Trial Commitments and Consulting: Boston
More informationMethods DEVICES AND TECHNOLOGY
DEVICES AND TECHNOLOGY Validation of the Omron HEM-907 device for blood pressure measurement Mohamed A. El Assaad, Jirar A. Topouchian, Bernadette M. Darné and Roland G. Asmar Background The aim of this
More informationHome blood pressure measurement with oscillometric upper-arm devices
REVIEW Home blood pressure measurement with oscillometric upper-arm devices R.L. Braam, Th. Thien *# Department of Internal Medicine, University Medical Centre St Radboud, PO Box 9101, 6500 HB Nijmegen,
More informationDISCLOSURES OUTLINE OUTLINE 9/29/2014 ANTI-HYPERTENSIVE MANAGEMENT OF CHRONIC KIDNEY DISEASE
ANTI-HYPERTENSIVE MANAGEMENT OF CHRONIC KIDNEY DISEASE DISCLOSURES Editor-in-Chief- Nephrology- UpToDate- (Wolters Klewer) Richard J. Glassock, MD, MACP Geffen School of Medicine at UCLA 1 st Annual Internal
More information